Springboard Health Angels
VC Fund
Berlin, Germany
Springboard Health Angels is a VC fund in Berlin focused on Health Care and Medical. Angel Syndicate investing in health tech out of Berlin
- Total investments:
- 25
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Springboard Health Angels invests in
Stages Springboard Health Angels invests in
Countries Springboard Health Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $932k–$5.8M
- Pre-Seed
- $400k–$3.8M
Investment Focus
Industry
- Health Care 17 (68%)
- Medical 7 (28%)
- Software 5 (20%)
- Health Diagnostics 5 (20%)
- Artificial Intelligence 5 (20%)
Stage
- Seed 11 (44%)
- Pre-Seed 8 (32%)
- Funding Round 4 (16%)
- Venture - Series Unknown 2 (8%)
Country
- Germany 11 (44%)
- United States 6 (24%)
- Switzerland 2 (8%)
- Sweden 1 (4%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ali Ciger
Angel Investor
|
Angel Investor | Total investments: 8 | Find email | |
Andreas Schmidt
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
Jan Weiss
Expert
|
Expert | Total investments: 0 | Find email | |
Yoni Goldwasser
Founder & Managing Director
|
Founder & Managing Director | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
MedGlance AI
|
MedGlance AI is a pioneering HealthTech platform that transforms complex medical reports into intuitive, patient-friendly visual protocols. Utilizing advanced Generative AI and the NanoBanana 2 (gemini-3-flash) engine, we provide real-time anatomical visualizations to improve health literacy and patient outcomes. Our "Zero-Retention"protocol ensures total data privacy, making us a trusted partner for healthcare providers and individual patients alike. We are dedicated to ensuring Health Equity through accessible, visual-first medical communication | $400K / Pre-Seed / Feb 12, 2026 | |
Cellbyte
|
Cellbyte is an AI based firm that offers safety and security standards for pharma companies to provide life-changing treatments to patients. | $2.8M / Seed / Nov 18, 2025 | |
Captain T Cell
|
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates. | $23.2M / Nov 17, 2025 | |
Andel
|
Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications. | $4.5M / Seed / Oct 20, 2025 | |
Qnomx
|
At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10million patients with metastatic cancer. Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed. | $1.9M / Pre-Seed / Apr 14, 2025 | |
Vivalyx
|
Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products. | $5.8M / Seed / Apr 30, 2024 | |
YonedaLabs
|
YonedaLabs is an AI-based software that assists chemists in optimizing reaction parameters such as temperature, concentration, and catalyst. | $4M / Seed / Apr 26, 2024 | |
roclub
|
roclub is a healthcare company that offers a teleoperation platform for MedTech. The platform enables MRI/CT scans to be carried out remotely, providing support and training for radiographers. The company's solution can bring medical technology, regardless of type, manufacturer, and installation site, into a managed system withoutintegrations plug-and-play. roclub also offers a bonus program for radiographers who recommend their solution to their employers. | $4.3M / Seed / Apr 25, 2024 | |
deepeye
|
deepeye® is a precision medicine platform for retinal diseases. It enables ophthalmologists to provide individual therapy to patients suffering from prevalent eye diseases like Age-related Macular Degeneration (AMD) or other retinal diseases which affect 12% of the EU+US population, thus preventing the causes of more than 66% of blindness'. | $2.7M / Seed / Nov 07, 2023 | |
PharmaCCX
|
PharmaCCX operates a market access platform with a simple and configurable infrastructure for planning, negotiating, and managing deals. The company software increases the capacity of market access teams at pharma and payers to plan, execute and administer innovative payment models | Seed / Jun 29, 2023 | |
| See all 25 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Springboard Health Angels invest in?
Springboard Health Angels invests primarily in Health Care, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 25 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Springboard Health Angels's check size?
Springboard Health Angels typically joins rounds of $932k–$5.8M at Seed and $400k–$3.8M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Springboard Health Angels participates in.
How do I contact Springboard Health Angels?
Public channels for Springboard Health Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Springboard Health Angels?
The team at Springboard Health Angels includes Ali Ciger (Angel Investor), Andreas Schmidt (Managing Director) and Jan Weiss (Expert). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
